Status:

COMPLETED

Topical Application of Low-concentration (0.01%) Atropine on the Human Eye With Fast and Slow Myopia Progression Rate

Lead Sponsor:

The Hong Kong Polytechnic University

Collaborating Sponsors:

The University of Hong Kong

Conditions:

Myopia

Eligibility:

All Genders

7-10 years

Phase:

NA

Brief Summary

Our project is a 24-month longitudinal randomized controlled trial that aims to investigate the myopia development after topical application of 0.01% atropine in children with either fast or slow myop...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • Age between 7 and 10 years
  • Good general health and no family history of ocular diseases
  • No current or history of epilepsy or asthma
  • Myopia : -0.50 to -1.00 D (inclusive, both eyes)
  • Astigmatism : ≤ 0.50 D
  • No hyperopia, amblyopia or strabismus
  • No reported ocular eye diseases or disorders
  • No drug allergy

Exclusion

    Key Trial Info

    Start Date :

    February 1 2018

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    August 31 2020

    Estimated Enrollment :

    71 Patients enrolled

    Trial Details

    Trial ID

    NCT03374306

    Start Date

    February 1 2018

    End Date

    August 31 2020

    Last Update

    October 16 2024

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    School of Optometry, Hong Kong Polytechnic University

    Hong Kong, Hong Kong, 00000